PGM5 and breast carcinoma: We found that PGM5 was downregulated in breast cancer patients and inhibited breast cancer cell proliferation, migration, and aerobic glycolysis, accompanied by altered expression of cell cycle- and apoptosis-related genes and EMT markers.